THE DOMAIN OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1 ESSENTIAL FOR BINDING TO ORIP REGION HAS A SEQUENCE FITTED FOR THE HYPOTHETICAL BASIC-HELIX-LOOP-HELIX STRUCTURE

被引:30
作者
INOUE, N [1 ]
HARADA, S [1 ]
HONMA, T [1 ]
KITAMURA, T [1 ]
YANAGI, K [1 ]
机构
[1] NATL INST HLTH,DEPT VIROL & RICKETTSIOL,KAMIOSAKI 2-10-35,SHINAGAWA KU,TOKYO 141,JAPAN
关键词
D O I
10.1016/0042-6822(91)90651-Q
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The domain of Epstein-Barr virus nuclear antigen 1 (EBNA-1) which is essential for binding to a region containing oriP, an episomal replication origin of EBV DNA, was analyzed by DNA binding assay with β-galactosidase-EBNA-1 fusion proteins. It was revealed that a 159-amino acid (aa) domain, 460-618 aa, of EBNA-1 retained the oriP-binding activity and the domain's activity was abolished by a deletion of 29 as from its amino-terminal end and by a 38 aa deletion from its carboxyl-end as well. One of five monoclonal antibodies against EBNA-1 specifically inhibited the binding of the β-galactosidase-EBNA-1 fusion protein to the oriP region. The epitope recognized by the monoclonal antibody was mapped in the crucial 29 as region. An analysis of the domain's putative secondary structure and a computer search of amino acid sequence homology indicated that the 159-aa domain contains the hypothetical basic-helix-loop-helix structure which is considered to be a common characteristic structure of a family of DNA binding proteins. Examinations of DNA binding activity of the other EBNA polypeptides with a series of fusion proteins and similar structural analyses of their amino acid sequences were also performed. This study suggests that EBNA-1 is a constituent of the family of DNA binding proteins which are involved in transcriptional regulation critical for cell differentiation or cell-type determination. © 1991.
引用
收藏
页码:84 / 93
页数:10
相关论文
共 57 条
[1]   DEFINITION OF THE SEQUENCE REQUIREMENTS FOR BINDING OF THE EBNA-1 PROTEIN TO ITS PALINDROMIC TARGET SITES IN EPSTEIN-BARR-VIRUS DNA [J].
AMBINDER, RF ;
SHAH, WA ;
RAWLINS, DR ;
HAYWARD, GS ;
HAYWARD, SD .
JOURNAL OF VIROLOGY, 1990, 64 (05) :2369-2379
[2]   THE HUMAN C-MYC-ONCOGENE - STRUCTURAL CONSEQUENCES OF TRANSLOCATION INTO THE IGH LOCUS IN BURKITT-LYMPHOMA [J].
BATTEY, J ;
MOULDING, C ;
TAUB, R ;
MURPHY, W ;
STEWART, T ;
POTTER, H ;
LENOIR, G ;
LEDER, P .
CELL, 1983, 34 (03) :779-787
[3]   TFE3 - A HELIX LOOP HELIX PROTEIN THAT ACTIVATES TRANSCRIPTION THROUGH THE IMMUNOGLOBULIN ENHANCER MU-E3 MOTIF [J].
BECKMANN, H ;
SU, LK ;
KADESCH, T .
GENES & DEVELOPMENT, 1990, 4 (02) :167-179
[4]   THE PROTEIN ID - A NEGATIVE REGULATOR OF HELIX-LOOP-HELIX DNA-BINDING PROTEINS [J].
BENEZRA, R ;
DAVIS, RL ;
LOCKSHON, D ;
TURNER, DL ;
WEINTRAUB, H .
CELL, 1990, 61 (01) :49-59
[5]   A PROMOTER FOR THE HIGHLY SPLICED EBNA FAMILY OF RNAS OF EPSTEIN-BARR-VIRUS [J].
BODESCOT, M ;
PERRICAUDET, M ;
FARRELL, PJ .
JOURNAL OF VIROLOGY, 1987, 61 (11) :3424-3430
[6]   DAUGHTERLESS, A DROSOPHILA GENE ESSENTIAL FOR BOTH NEUROGENESIS AND SEX DETERMINATION, HAS SEQUENCE SIMILARITIES TO MYC AND THE ACHAETE-SCUTE COMPLEX [J].
CAUDY, M ;
VASSIN, H ;
BRAND, M ;
TUMA, R ;
JAN, LY ;
JAN, YN .
CELL, 1988, 55 (06) :1061-1067
[7]   FUNCTIONAL LIMITS OF ORIP, THE EPSTEIN-BARR VIRUS PLASMID ORIGIN OF REPLICATION [J].
CHITTENDEN, T ;
LUPTON, S ;
LEVINE, AJ .
JOURNAL OF VIROLOGY, 1989, 63 (07) :3016-3025
[8]   EPSTEIN-BARR VIRUS NUCLEAR PROTEIN-2 IS A KEY DETERMINANT OF LYMPHOCYTE-TRANSFORMATION [J].
COHEN, JI ;
WANG, F ;
MANNICK, J ;
KIEFF, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9558-9562
[9]   EPSTEIN-BARR VIRUS (B95-8) DNA .7. MOLECULAR-CLONING AND DETAILED MAPPING [J].
DAMBAUGH, T ;
BEISEL, C ;
HUMMEL, M ;
KING, W ;
FENNEWALD, S ;
CHEUNG, A ;
HELLER, M ;
RAABTRAUB, N ;
KIEFF, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2999-3003
[10]   EXPRESSION OF A SINGLE TRANSFECTED CDNA CONVERTS FIBROBLASTS TO MYOBLASTS [J].
DAVIS, RL ;
WEINTRAUB, H ;
LASSAR, AB .
CELL, 1987, 51 (06) :987-1000